Pre-Pregnancy Genetic Testing Market By Test Type (Screening Test (Maternal Serum Quad Screening, Sequential Screening & Carrier Screening) and Diagnostic Test (Fetal Biopsy, Placental Biopsy, Cordocentesis, Amniocentesis & Chorionic Villi Samplin)) and End User (Diagnostic Centers, Clinics and Hospitals) - Global Industry Analysis And Forecast To 2027

Published On : September 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC091283

SEGMENTS & REGIONS:

  • By Test Type: Screening Test (Maternal Serum Quad Screening, Sequential Screening & Carrier Screening
  • and Diagnostic Test: Fetal Biopsy, Placental Biopsy, Cordocentesis, Amniocentesis & Chorionic Villi Samplin
  • and End User: Diagnostic Centers, Clinics and Hospitals
  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Industry Outlook

Pre-Pregnancy Genetic Testing is carried out for analyzing genetic disorders if any, if tested negative the couple is reassured that the child born will have small chances of getting affected by the disorder. Use of Pre-Pregnancy Genetic Testing is growing due to; rising knowledge about the genetic conditions amongst the parents expecting child, delayed pregnancy in urban parents, technical advancement in the testing procedures & equipment’s used for the same, increased convenience & reliability of the tests, increasing expenditure on healthcare sector in many developing countries, lifestyle change, rising number of cases related to chromosomal abnormalities, etc. Therefore, the Pre-Pregnancy Genetic Testing Market is anticipated to expand and has tremendous scope during the forecast period. The global Pre-Pregnancy Genetic Testing Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Pre-Pregnancy Genetic Testing Market is based on segment, by Test Type the market is segmented into Screening Test (Maternal Serum Quad Screening, Sequential Screening & Carrier Screening) and Diagnostic Test (Fetal Biopsy, Placental Biopsy, Cordocentesis, Amniocentesis & Chorionic Villi Sampling (CVS)), and by End User the market is segmented into Diagnostic Centers, Clinics and Hospitals.

  • Pre-Pregnancy Genetic Testing Market, By Test Type
  • Screening Test
  • Maternal Serum Quad Screening
  • Sequential Screening
  • Carrier Screening
  • Diagnostic Test
  • Fetal Biopsy
  • Placental Biopsy
  • Cordocentesis
  • Amniocentesis
  • Chorionic Villi Sampling (CVS)
  • Pre-Pregnancy Genetic Testing Market, By End User
  • Diagnostic Centers
  • Clinics
  • Hospitals

Regional Insights

On a global front, the Pre-Pregnancy Genetic Testing Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Pre-Pregnancy Genetic Testing Market and will lead during the forecasted period.

 

Pre-Pregnancy Genetic Testing Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Ariosa Diagnostics Inc., LifeCodexx, Sequenom Laboratories, Natera, BGI Health, Illumina Inc. and Natera Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Ariosa Diagnostics Inc.
  • LifeCodexx
  • Sequenom Laboratories
  • Natera
  • BGI Health
  • Illumina Inc.
  • Natera Inc.

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Pre-Pregnancy Genetic Testing Market, By Test Type, Estimates and Forecast, 2017-2027 ($Million)

o   Screening Test

§  Maternal Serum Quad Screening

§  Sequential Screening

§  Carrier Screening

o   Diagnostic Test

§  Fetal Biopsy

§  Placental Biopsy

§  Cordocentesis

§  Amniocentesis

§  Chorionic Villi Sampling (CVS)

o   Pre-Pregnancy Genetic Testing Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Diagnostic Centers

o   Clinics

o   Hospitals

o   Pre-Pregnancy Genetic Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Pre-Pregnancy Genetic Testing Market, By Country

o   U.S. Pre-Pregnancy Genetic Testing Market

o   Canada Pre-Pregnancy Genetic Testing Market

o   Mexico Pre-Pregnancy Genetic Testing Market

o   Europe

§  Europe Pre-Pregnancy Genetic Testing Market, By Country

o   Germany Pre-Pregnancy Genetic Testing Market

o   UK Pre-Pregnancy Genetic Testing Market

o   France Pre-Pregnancy Genetic Testing Market

o   Russia Pre-Pregnancy Genetic Testing Market

o   Italy Pre-Pregnancy Genetic Testing Market

o   Rest of Europe Pre-Pregnancy Genetic Testing Market

o   Asia-Pacific

§  Asia-Pacific Pre-Pregnancy Genetic Testing Market, By Country

o   China Pre-Pregnancy Genetic Testing Market

o   Japan Pre-Pregnancy Genetic Testing Market

o   South Korea  Pre-Pregnancy Genetic Testing Market

o   India Pre-Pregnancy Genetic Testing Market

o   Southeast Asia Pre-Pregnancy Genetic Testing Market

o   Rest of Asia-Pacific Pre-Pregnancy Genetic Testing Market

o   South America

§  South America Pre-Pregnancy Genetic Testing Market, By Country

o   Brazil Pre-Pregnancy Genetic Testing Market

o   Argentina Pre-Pregnancy Genetic Testing Market

o   Columbia Pre-Pregnancy Genetic Testing Market

o   Rest of South America Pre-Pregnancy Genetic Testing Market

o   Middle East and Africa

§  Middle East and Africa Pre-Pregnancy Genetic Testing Market, By Country

o   Saudi Arabia Pre-Pregnancy Genetic Testing Market

o   UAE Pre-Pregnancy Genetic Testing Market

o   Egypt Pre-Pregnancy Genetic Testing Market

o   Nigeria Pre-Pregnancy Genetic Testing Market

o   South Africa Pre-Pregnancy Genetic Testing Market

o   Rest of MEA Pre-Pregnancy Genetic Testing Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Pre-Pregnancy Genetic Testing  Market, By Test Type

5.1.     Introduction

5.2.     Global Pre-Pregnancy Genetic Testing  Revenue and Market Share by Test Type (2017-2027)

5.2.1.  Global Pre-Pregnancy Genetic Testing  Revenue and Revenue Share by Test Type (2017-2027)

5.3.     Screening Test

5.3.1.  Global Screening Test Revenue and Growth Rate (2017-2027)

5.3.2.  Global Screening Test By Type (2017-2027)

5.3.3.  Maternal Serum Quad Screening

5.3.3.1.  Global Maternal Serum Quad Screening Revenue and Growth Rate (2017-2027)

5.3.4.  Sequential Screening

5.3.4.1.  Global Sequential Screening Revenue and Growth Rate (2017-2027)

5.3.5.  Carrier Screening

5.3.5.1.  Global Carrier Screening Revenue and Growth Rate (2017-2027)

5.4.     Diagnostic Test

5.4.1.  Global Diagnostic Test Revenue and Growth Rate (2017-2027)

5.4.2.  Global Diagnostic Test By Type (2017-2027)

5.4.3.  Fetal Biopsy

5.4.3.1.  Global Fetal Biopsy Revenue and Growth Rate (2017-2027)

5.4.4.  Placental Biopsy

5.4.4.1.  Global Placental Biopsy Revenue and Growth Rate (2017-2027)

5.4.5.  Cordocentesis

5.4.5.1.  Global Cordocentesis Revenue and Growth Rate (2017-2027)

5.4.6.  Amniocentesis

5.4.6.1.  Global Amniocentesis Revenue and Growth Rate (2017-2027)

5.4.7.  Chorionic Villi Sampling (CVS)

5.4.7.1.  Global Chorionic Villi Sampling (CVS) Revenue and Growth Rate (2017-2027)

6.       Pre-Pregnancy Genetic Testing  Market, By End User

6.1.     Introduction

6.2.     Global Pre-Pregnancy Genetic Testing  Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Pre-Pregnancy Genetic Testing  Revenue and Revenue Share by End User (2017-2027)

6.3.     Diagnostic Centers

6.3.1.  Global Diagnostic Centers Revenue and Growth Rate (2017-2027)

6.4.     Clinics

6.4.1.  Global Clinics Revenue and Growth Rate (2017-2027)

6.5.     Hospitals

6.5.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

7.       Pre-Pregnancy Genetic Testing  Market, By Region

7.1.     Introduction

7.2.     Global Pre-Pregnancy Genetic Testing  Revenue and Market Share by Regions

7.2.1.  Global Pre-Pregnancy Genetic Testing  Revenue by Regions (2017-2027)

7.3.     North America Pre-Pregnancy Genetic Testing  by Countries

7.3.1.  North America Pre-Pregnancy Genetic Testing  Revenue and Growth Rate (2017-2027)

7.3.2.  North America Pre-Pregnancy Genetic Testing  Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Pre-Pregnancy Genetic Testing  by Countries

7.4.1.  Europe Pre-Pregnancy Genetic Testing  Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Pre-Pregnancy Genetic Testing  Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Pre-Pregnancy Genetic Testing  by Countries

7.5.1.  Asia-Pacific Pre-Pregnancy Genetic Testing  Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Pre-Pregnancy Genetic Testing  Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Pre-Pregnancy Genetic Testing  by Countries

7.6.1.  South America Pre-Pregnancy Genetic Testing  Revenue and Growth Rate (2017-2027)

7.6.2.  South America Pre-Pregnancy Genetic Testing  Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Pre-Pregnancy Genetic Testing  by Countries

7.7.1.  Middle East and Africa Pre-Pregnancy Genetic Testing  Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Pre-Pregnancy Genetic Testing  Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Ariosa Diagnostics Inc.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     LifeCodexx

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Sequenom Laboratories

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Natera

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     BGI Health

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Illumina Inc.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Natera Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

9.       Global Pre-Pregnancy Genetic Testing  Market Competition, by Manufacturer

9.1.     Global Pre-Pregnancy Genetic Testing  Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Pre-Pregnancy Genetic Testing  Price By Region (2017-2017)

9.3.     Top 5 Pre-Pregnancy Genetic Testing  Manufacturer Market Share

9.4.     Market Competition Trend

10.    Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.1. Global Pre-Pregnancy Genetic Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Pre-Pregnancy Genetic Testing  Market Forecast by Regions (2017-2027)

10.2.1.      North America Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.1.1. United States Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.1.2. Canada Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.1.3. Mexico Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.      Europe Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.1. Germany Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.2. France Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.3. UK Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.4. Russia Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.5. Italy Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.1. China Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.2. Japan Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.3. Korea Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.4. India Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.4.      South America Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.4.1. Brazil Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.4.2. Argentina Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.4.3. Columbia Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.4.4. Rest of South America Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.3. Egypt Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.4. Nigeria Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.5. South Africa Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.6. Turkey Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Pre-Pregnancy Genetic Testing  Market Forecast (2017-2027)

10.3. Pre-Pregnancy Genetic Testing  Market Forecast by Test Type (2017-2027)

10.3.1.      Pre-Pregnancy Genetic Testing  Forecast by Test Type (2017-2027)

10.3.2.      Pre-Pregnancy Genetic Testing  Market Share Forecast by Test Type (2017-2027)

10.4. Pre-Pregnancy Genetic Testing  Market Forecast by End User (2017-2027)

10.4.1.      Pre-Pregnancy Genetic Testing  Forecast by End User (2017-2027)

10.4.2.      Pre-Pregnancy Genetic Testing  Market Share Forecast by End User (2017-2027)


List of Tables

11. List of Tables and Figures
Figure United States Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Pre-Pregnancy Genetic Testing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Pre-Pregnancy Genetic Testing Revenue and Revenue Share by Test Type (2017-2018)
Figure Global Screening Test Revenue and Growth Rate (2017-2018)
Figure Global Maternal Serum Quad Screening Revenue and Growth Rate (2017-2018)
Figure Global Sequential Screening Revenue and Growth Rate (2017-2018)
Figure Global Carrier Screening Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Test Revenue and Growth Rate (2017-2018)
Figure Global Fetal Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Placental Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Cordocentesis Revenue and Growth Rate (2017-2018)
Figure Global Amniocentesis Revenue and Growth Rate (2017-2018)
Figure Global Chorionic Villi Sampling (CVS) Revenue and Growth Rate (2017-2018)
Table Global Pre-Pregnancy Genetic Testing Revenue and Revenue Share by End User (2017-2018)
Figure Global Diagnostic Centers Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Pre-Pregnancy Genetic Testing Revenue by Regions (2017-2018)
Figure North America Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure North America Pre-Pregnancy Genetic Testing Revenue and Growth Rate (2017-2018)
Figure North America Pre-Pregnancy Genetic Testing by Countries (2017-2018)
Figure North America Pre-Pregnancy Genetic Testing Revenue (Million USD) by Countries (2017-2018)
Figure United States Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure United States Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Canada Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Mexico Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Europe Pre-Pregnancy Genetic Testing Revenue and Growth Rate (2017-2018)
Figure Europe Pre-Pregnancy Genetic Testing by Countries (2017-2018)
Figure Europe Pre-Pregnancy Genetic Testing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Germany Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure France Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure UK Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Russia Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Italy Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Rest of Europe Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Asia-Pacific Pre-Pregnancy Genetic Testing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Pre-Pregnancy Genetic Testing by Countries (2017-2018)
Figure Asia-Pacific Pre-Pregnancy Genetic Testing Revenue (Million USD) by Countries (2017-2018)
Figure China Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure China Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Japan Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Korea Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure India Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Southeast Asia Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure South America Pre-Pregnancy Genetic Testing Revenue and Growth Rate (2017-2018)
Figure South America Pre-Pregnancy Genetic Testing by Countries (2017-2018)
Figure South America Pre-Pregnancy Genetic Testing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Brazil Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Argentina Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Columbia Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Rest of South America Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Middle East and Africa Pre-Pregnancy Genetic Testing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Pre-Pregnancy Genetic Testing by Countries (2017-2018)
Figure Middle East and Africa Pre-Pregnancy Genetic Testing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Saudi Arabia Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure United Arab Emirates Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Egypt Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Nigeria Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure South Africa Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Turkey Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pre-Pregnancy Genetic Testing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Table Ariosa Diagnostics Inc. Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table LifeCodexx Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sequenom Laboratories Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Natera Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table BGI Health Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Illumina Inc. Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Natera Inc. Pre-Pregnancy Genetic Testing Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Pre-Pregnancy Genetic Testing Market Share by Manufacturer
Figure Global Pre-Pregnancy Genetic Testing Revenue and Market Share by Manufacturer
Table Global Pre-Pregnancy Genetic Testing Price by Region (2017-2017)
Figure Top 5 Pre-Pregnancy Genetic Testing Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Pre-Pregnancy Genetic Testing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Pre-Pregnancy Genetic Testing Market Forecast by Regions (2018-2025)
Figure North America Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure United States Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Canada Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Mexico Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Europe Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Germany Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure France Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure UK Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Russia Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Italy Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Rest of Europe Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Asia-Pacific Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure China Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Japan Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Korea Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure India Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Southeast Asia Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure South America Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Brazil Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Argentina Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Columbia Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Rest of South America Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Middle East and Africa Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Saudi Arabia Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure United Arab Emirates Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Egypt Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Nigeria Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure South Africa Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Turkey Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Pre-Pregnancy Genetic Testing Market Forecast (2018-2025)
Figure Global Pre-Pregnancy Genetic Testing Forecast by Test Type (2018-2025)
Figure Global Pre-Pregnancy Genetic Testing Market Share Forecast by Test Type (2018-2025)
Figure Global Pre-Pregnancy Genetic Testing Forecast by Test Type (2018-2025)
Figure Global Pre-Pregnancy Genetic Testing Forecast by End User (2018-2025)
Figure Global Pre-Pregnancy Genetic Testing Market Share Forecast by End User (2018-2025)
Figure Global Pre-Pregnancy Genetic Testing Forecast by End User (2018-2025)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country